跳至主要内容
临床试验/NCT06009549
NCT06009549尚未招募不适用

Engagement Trends in Clinical Trials for Metastatic Prostate Cancer - A Journey Into Participation Patterns Among Individuals Affected by the Condition

Power Life Sciences Inc.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年9月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
Number of patients who decide to participate in a metastatic prostate cancer clinical research

研究概览

简要总结

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This research will admit a wide range of data on the clinical study experience of metastatic prostate cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with metastatic prostate cancer.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patient is at least 18 years of age
  • Diagnosis of metastatic prostate cancer
  • Ability to understand and the willingness to sign a written informed consent document

排除标准

  • Enrolled in another research study
  • Patients with psychiatric illness/social situations that would limit compliance with study requirements
  • Inability to provide written informed consent

结局指标

主要结局

Number of patients who decide to participate in a metastatic prostate cancer clinical research

时间窗: 3 months

Rate of patients who remain in metastatic prostate cancer clinical research to trial completion

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验